MedPath

The First Clinical Trial Of A Combination of Traditional Medicine in Primery Hypertensio

Phase 4
Conditions
Primery hypertention.
Primery hypertention
Registration Number
IRCT2015031821512N1
Lead Sponsor
Vice Channcellor for Rresearch, Zanjan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
36
Inclusion Criteria

All women and men in the age range 30 to 75 years old in the first and second primary hypertension clinic University of Medical Sciences with stakeholders, especially not out of the study. Exclusion criteria: Severe hypertension, hypertensive secondary, signs of organ damage at the end of the 6 months prior to the study, a sudden increase in blood pressure over 15 mm Hg; patient's blood pressure greater than or equal to 110 to 180 mm Hg, a variety of cardiac arrhythmias, valvular disease symptomatic heart disease, impaired liver function, pregnancy or lactation, serum potassium more than 5.5 or less than 5.3 equivalent in business l First, any disruption (medical or surgical) that, the researcher could interfere with the study, drugs interfering with hypertension, psychiatric disorders such as anxiety, depression and obsessive-compulsive or psychiatric drugs

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primery hypertention. Timepoint: 1/2weak. Method of measurement: Measuring Devices.
Secondary Outcome Measures
NameTimeMethod
Meezaj. Timepoint: Baseline. Method of measurement: questionnaire.
© Copyright 2025. All Rights Reserved by MedPath